Insider Trading Activity For OPKO Health (NASDAQ:OPK)
Phillip Md Et Al Frost , CEO of OPKO Health (NASDAQ:OPK) reportedly Bought 55,372 shares of the company’s stock at an average price of 2.99 for a total transaction amount of $165,562.28 SEC Form
Insider Trading History For OPKO Health (NASDAQ:OPK)
Analyst Ratings History For OPKO Health (NASDAQ:OPK)
- On 6/16/2016 Deutsche Bank Lower Price Target of rating Hold with a price target of $11.00 to $10.00
- On 10/10/2016 Oppenheimer Reiterated Rating Hold
- On 1/3/2017 Laidlaw Reiterated Rating Buy with a price target of $22.00 to $19.00
- On 3/5/2017 Standpoint Research Reiterated Rating Buy with a price target of $14.00
- On 3/14/2017 Guggenheim Initiated Coverage of rating Buy with a price target of $25.00
- On 7/18/2017 Barrington Research Boost Price Target of rating Outperform with a price target of $11.00
- On 8/10/2017 Jefferies Group Reiterated Rating Hold with a price target of $6.80 to $6.50
Recent Trading Activity for OPKO Health (NASDAQ:OPK)
Shares of OPKO Health closed the previous trading session at 3.04 +0.00 0.00% with shares trading hands.